<DOC>
	<DOC>NCT01018342</DOC>
	<brief_summary>The objective of this study was to investigate the bioequivalence of Mylan nitrofurantoin monohydrate/macrocrystals capsules to Procter &amp; Gamble Macrobid® capsules following a single, oral 100 mg (1 x 100 mg) dose under fed conditions.</brief_summary>
	<brief_title>Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg</brief_title>
	<detailed_description />
	<mesh_term>Nitrofurantoin</mesh_term>
	<criteria>healthy, adult subjects, 18 years and older able to swallow medication institutionalized subjects history of any significant disease use of any prescription or OTC medications within 14 days of start of study received any investigational products within 30 days prior to start of study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>